doi: 10.2147/nedt.2007.3.1.59.
Venlafaxine in the treatment of panic disorder
Affiliations
- PMID: 19300538
- PMCID: PMC2654536
- DOI: 10.2147/nedt.2007.3.1.59
Item in Clipboard
Venlafaxine in the treatment of panic disorder
Neuropsychiatr Dis Treat.
2007 Feb.
Abstract
Venlafaxine XR is a novel, dual acting SNRI antidepressant, which inhibits both serotonin and norepinephrine reuptake. Controlled trials have demonstrated the efficacy and safety of venlafaxine in the treatment of panic disorder. Generally well tolerated, with side-effects that usually abate with continued treatment, venlafaxine is an important option to the SSRIs for the treatment of patients with panic disorder.
Keywords: antidepressant therapy; anxiety disorders; panic disorder; remission; selective serotonin norepinephrine reuptake inhibitor; venlafaxine.
Similar articles
-
Venlafaxine in the treatment of anxiety disorders.Expert Rev Neurother. 2004 May;4(3):371-81. doi: 10.1586/14737175.4.3.371. Expert Rev Neurother. 2004. PMID: 15853535 Review.
-
Treatment of anxiety disorders with venlafaxine XR.Expert Rev Neurother. 2006 Mar;6(3):269-82. doi: 10.1586/14737175.6.3.269. Expert Rev Neurother. 2006. PMID: 16533131 Review.
-
Serotonin and Norepinephrine Reuptake Inhibitors.Handb Exp Pharmacol. 2019;250:145-180. doi: 10.1007/164_2018_164. Handb Exp Pharmacol. 2019. PMID: 30838456
-
Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder.Expert Opin Pharmacother. 2023 Sep-Dec;24(15):1715-1723. doi: 10.1080/14656566.2023.2242264. Epub 2023 Aug 7. Expert Opin Pharmacother. 2023. PMID: 37501324 Review.
-
Bupropion: a review of its use in the management of major depressive disorder.Drugs. 2008;68(5):653-89. doi: 10.2165/00003495-200868050-00011. Drugs. 2008. PMID: 18370448 Review.
Cited by
-
Sleep Deprivation-Induced Anxiety Alleviated by Oral Administration of 4-Aminopyridine in Male Mice.Brain Behav. 2025 Mar;15(3):e70382. doi: 10.1002/brb3.70382. Brain Behav. 2025. PMID: 40059459 Free PMC article.
-
Treatment of generalized anxiety disorder.Neuropsychiatr Dis Treat. 2007 Apr;3(2):183-4. doi: 10.2147/nedt.2007.3.2.183. Neuropsychiatr Dis Treat. 2007. PMID: 19300551 Free PMC article. No abstract available.
-
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder.Ann Gen Psychiatry. 2018 May 11;17:19. doi: 10.1186/s12991-018-0190-6. eCollection 2018. Ann Gen Psychiatry. 2018. PMID: 29760763 Free PMC article.
References
-
- Albers L, Reist C, Vu R, et al. Effect of venlafaxine on imipramine metabolism. Psychiatry Res. 2000;96:235–43. - PubMed
-
- Amchin J, Zarycranski W, Taylor KP, et al. Effect of venlafaxine on the pharmacokinetics of risperidone. J Clin Pharmacol. 1999;39:297–09. - PubMed
-
- [APA] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: APA; 1994.
-
- [APA] American Psychiatric Association. Practice Guideline for the Treatment of Patients with Panic disorder. Washington, DC: APA; 1998. - PubMed
-
- Ballenger J. Treatment of anxiety disorders to remission. The J Clin Psychiatry. 2001;62(Suppl 12):5–9. - PubMed
LinkOut - more resources
Full Text Sources
